Mostrar el registro sencillo del ítem

Safety and efficacy of asciminib treatment in chronic myeloid leukemia patients in real-life clinical practice

dc.contributor.authorGarcia-Gutiérrez, V.
dc.contributor.authorLuna, A.
dc.contributor.authorAlonso-Dominguez, J.M.
dc.contributor.authorEstrada, N.
dc.contributor.authorBoque, C.
dc.contributor.authorXicoy, B.
dc.contributor.authorGiraldo, P.
dc.contributor.authorAngona, A.
dc.contributor.authorAlvarez-Larrán, A.
dc.contributor.authorSanchez-Guijo, F.
dc.contributor.authorRamírez, M.J.
dc.contributor.authorMora, E.
dc.contributor.authorVélez, P.
dc.contributor.authorRosell, A.
dc.contributor.authorColorado Araujo, M.
dc.contributor.authorCuevas, B.
dc.contributor.authorSagüés, M.
dc.contributor.authorCortes, M.
dc.contributor.authorPérez Encinas, Manuel Mateo 
dc.contributor.authorCasado Montero, L.F.
dc.contributor.authorMoreno Vega, M.
dc.contributor.authorSerrano, L.
dc.contributor.authorGomez, V.
dc.contributor.authorGarcia-Hernandez, C.
dc.contributor.authorLakhwani, S.
dc.contributor.authorPaz Coll, A.
dc.contributor.authorde Paz, R.
dc.contributor.authorSuarez-Varela, S.
dc.contributor.authorFernandez-Ruiz, A.
dc.contributor.authorPerez Lopez, R.
dc.contributor.authorOrtiz-Fernández, A.
dc.contributor.authorJiménez-Velasco, A.
dc.contributor.authorSteegmann-Olmedillas, J.L.
dc.contributor.authorHernández-Boluda, J.C.
dc.date.accessioned2025-08-12T11:28:12Z
dc.date.available2025-08-12T11:28:12Z
dc.date.issued2021
dc.identifier.citationGarcia-Gutiérrez V, Luna A, Alonso-Dominguez JM, Estrada N, Boque C, Xicoy B, et al. Safety and efficacy of asciminib treatment in chronic myeloid leukemia patients in real-life clinical practice. Blood Cancer Journal. 2021;11(2)
dc.identifier.issn2044-5385
dc.identifier.otherhttps://sergas.portalcientifico.es//documentos/605a0f863d93f26dffb4e27a
dc.identifier.urihttp://hdl.handle.net/20.500.11940/20381
dc.language.isoeng
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subject.meshAdult *
dc.subject.meshAged *
dc.subject.meshAged, 80 and over *
dc.subject.meshFemale *
dc.subject.meshFusion Proteins, bcr-abl*
dc.subject.meshHumans *
dc.subject.meshLeukemia, Myelogenous, Chronic, BCR-ABL Positive *
dc.subject.meshMale *
dc.subject.meshMiddle Aged *
dc.subject.meshNiacinamide *
dc.subject.meshProtein Kinase Inhibitors *
dc.subject.meshPyrazoles *
dc.subject.meshTreatment Outcome *
dc.subject.meshYoung Adult *
dc.titleSafety and efficacy of asciminib treatment in chronic myeloid leukemia patients in real-life clinical practice
dc.typeArticle
dc.rights.licenseAtribución 4.0 Internacional*
dc.authorsophosGarcia-Gutiérrez, V.
dc.authorsophosLuna, A.
dc.authorsophosAlonso-Dominguez, J.M.
dc.authorsophosEstrada, N.
dc.authorsophosBoque, C.
dc.authorsophosXicoy, B.
dc.authorsophosGiraldo, P.
dc.authorsophosAngona, A.
dc.authorsophosAlvarez-Larrán, A.
dc.authorsophosSanchez-Guijo, F.
dc.authorsophosRamírez, M.J.
dc.authorsophosMora, E.
dc.authorsophosVélez, P.
dc.authorsophosRosell, A.
dc.authorsophosColorado Araujo, M.
dc.authorsophosCuevas, B.
dc.authorsophosSagüés, M.
dc.authorsophosCortes, M.
dc.authorsophosEncinas, M.P.
dc.authorsophosCasado Montero, L.F.
dc.authorsophosMoreno Vega, M.
dc.authorsophosSerrano, L.
dc.authorsophosGomez, V.
dc.authorsophosGarcia-Hernandez, C.
dc.authorsophosLakhwani, S.
dc.authorsophosPaz Coll, A.
dc.authorsophosde Paz, R.
dc.authorsophosSuarez-Varela, S.
dc.authorsophosFernandez-Ruiz, A.
dc.authorsophosPerez Lopez, R.
dc.authorsophosOrtiz-Fernández, A.
dc.authorsophosJiménez-Velasco, A.
dc.authorsophosSteegmann-Olmedillas, J.L.
dc.authorsophosHernández-Boluda, J.C.
dc.identifier.doi10.1038/S41408-021-00420-8
dc.identifier.sophos605a0f863d93f26dffb4e27a
dc.issue.number2
dc.journal.titleBlood Cancer Journalen
dc.relation.publisherversionhttps://doi.org/10.1038/s41408-021-00420-8
dc.rights.accessRightsopenAccess*
dc.subject.keywordAS Santiago AP
dc.subject.keywordCHUS
dc.typefidesArtículo de Opinión
dc.typesophosArtículo Original
dc.volume.number11


Ficheros en el ítem

Descargar/
Nombre:
Blood Cancer Journal. 2021;11(2)
Tamaño:
229.7Kb
Formato:
PDF

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución 4.0 Internacional